Review
Published on 29 Sep 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of dose
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1016894
- 8,138 views
- 5 citations
Type at least 3 characters
1,882 articles
articles
Review
Published on 29 Sep 2022
From women to women—hematuria during therapy for metastatic breast cancer, what to suspect and when to be alarmed; Bladder metastasis from breast cancer—our experience and a systematic literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.976947
- 9,379 views
- 7 citations
Original Research
Published on 28 Sep 2022
Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.949058
- 4,642 views
- 12 citations
Original Research
Published on 28 Sep 2022
CT-based transformer model for non-invasively predicting the Fuhrman nuclear grade of clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.961779
- 4,067 views
- 17 citations
Original Research
Published on 28 Sep 2022
Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1013324
- 2,985 views
- 5 citations
Original Research
Published on 28 Sep 2022
Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.924072
- 1,959 views
Original Research
Published on 28 Sep 2022
Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.981226
- 5,228 views
- 9 citations
Editorial
Published on 28 Sep 2022
Editorial: Women in genitourinary oncology: 2021
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1027852
- 4,754 views
Original Research
Published on 27 Sep 2022
Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.947445
- 4,573 views
- 7 citations
Original Research
Published on 27 Sep 2022
Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1024342
- 2,629 views
- 1 citation
Original Research
Published on 27 Sep 2022
Fusing hand-crafted and deep-learning features in a convolutional neural network model to identify prostate cancer in pathology images
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.994950
- 7,651 views
- 29 citations
Original Research
Published on 27 Sep 2022
PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.911466
- 5,199 views
- 20 citations
Original Research
Published on 27 Sep 2022
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.969569
- 3,818 views
- 8 citations
Editorial
Published on 26 Sep 2022
Editorial: Penile cancer in genitourinary oncology
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1040950
- 4,988 views
- 1 citation
Original Research
Published on 26 Sep 2022
Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.991368
- 4,435 views
- 6 citations
Original Research
Published on 23 Sep 2022
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.964672
- 2,498 views
- 2 citations
Review
Published on 23 Sep 2022
Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.980239
- 21,656 views
- 39 citations
Systematic Review
Published on 23 Sep 2022
Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.954495
- 2,709 views
- 7 citations
Case Report
Published on 23 Sep 2022
Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.985177
- 2,827 views
- 2 citations
Technology and Code
Published on 23 Sep 2022
Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.992032
- 3,560 views
- 1 citation
Original Research
Published on 23 Sep 2022
Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1009014
- 4,336 views
- 10 citations
Original Research
Published on 23 Sep 2022
Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.972572
- 3,885 views
- 9 citations
Original Research
Published on 23 Sep 2022
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955501
- 3,963 views
- 14 citations
Review
Published on 23 Sep 2022
To bind or not to bind: Cistromic reprogramming in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.963007
- 6,499 views
- 13 citations